Hyper Corporation Inc. (KOSDAQ:065650)

South Korea flag South Korea · Delayed Price · Currency is KRW
214.00
-5.00 (-2.28%)
At close: May 2, 2025, 3:30 PM KST
-85.50%
Market Cap 23.22B
Revenue (ttm) 58.46B
Net Income (ttm) -80.36B
Shares Out 106.51M
EPS (ttm) -927.65
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 481,252
Average Volume 1,305,080
Open 219.00
Previous Close 219.00
Day's Range 212.00 - 225.00
52-Week Range 178.00 - 1,592.00
Beta 1.22
RSI 41.85
Earnings Date May 12, 2025

About Hyper Corporation

Hyper Corporation Inc., a clinical stage biopharmaceutical company, focuses on the development of Alzheimer's disease (AD) and neuropathic pain treatments, and AD diagnostics. Its products under development include TRPV1 Antagonist and TRPV1 Agonist for neuropathic pain; and anti-oligomerization of beta-amyloid, receptor for advanced glycation endproduct modulator, and early diagnosis kits for AD. The company wholesales and retails electronic devices, small home appliances, TVs, routers, and PC peripherals, such as gaming monitors, mouse, and w... [Read more]

Industry Computer Programming, Data Processing, And Other Computer Related Services
Founded 1997
Employees 33
Stock Exchange KOSDAQ
Ticker Symbol 065650
Full Company Profile

Financial Performance

In 2024, Hyper Corporation's revenue was 58.46 billion, an increase of 36.33% compared to the previous year's 42.88 billion. Losses were -80.36 billion, 3999.0% more than in 2023.

Financial Statements

News

There is no news available yet.